Biocartis Group NV (LTS:0R72) Quick Ratio: 1.60 (As of Jun. 2023)


LTS:0R72 Biocartis Group NV LTS:0R72
14 GF Score
Price €0.30
View Full Analysis

What is Biocartis Group NV Quick Ratio?

Biocartis Group NV LTS:0R72 14 Quick Ratio is 1.60 as of Jun. 2023. GuruFocus rates LTS:0R72 with a GF Score™ of 14/100.

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Biocartis Group NV's quick ratio for the quarter that ended in Jun. 2023 was 1.60.

Biocartis Group NV has a quick ratio of 1.60. It generally indicates good short-term financial strength.

The historical rank and industry rank for Biocartis Group NV's Quick Ratio or its related term are showing as below:

LTS:0R72's Quick Ratio is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 1.69
* Ranked among companies with meaningful Quick Ratio only.

Biocartis Group NV  (LTS:0R72) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Biocartis Group NV Quick Ratio Related Terms


Biocartis Group NV Quick Ratio Historical Data

* Premium members only.

The historical data trend for Biocartis Group NV's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biocartis Group NV Quick Ratio Chart

Biocartis Group NV Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Quick Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.89 8.65 4.90 2.34 1.20

Biocartis Group NV Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.77 2.34 1.56 1.20 1.60

LTS:0R72 vs TMO, DHR, IDXX: Quick Ratio Comparison

For the Diagnostics & Research subindustry, Biocartis Group NV's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biocartis Group NV Quick Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Biocartis Group NV's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Biocartis Group NV's Quick Ratio falls into.


LTS:0R72
14GF Score
Biocartis Group NV LTS:0R72
Quick Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biocartis Group NV Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Biocartis Group NV's Quick Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Quick Ratio (A: Dec. 2022 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(69.934-18.905)/42.449
=1.20

Biocartis Group NV's Quick Ratio for the quarter that ended in Jun. 2023 is calculated as

Quick Ratio (Q: Jun. 2023 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(69.629-17.884)/32.409
=1.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Quick Ratio →
What does a Quick Ratio of 1.60 mean?
Biocartis Group NV (LTS:0R72) has a Quick Ratio of 1.60 as of Jun. 2023. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Biocartis Group NV and its competitors.
Is Biocartis Group NV's Quick Ratio too high?
Biocartis Group NV's current Quick Ratio is 1.60. The Medical Diagnostics & Research industry median Quick Ratio is 1.69. Biocartis Group NV's value of 1.60 is 5.3% below this industry median. Overall, Biocartis Group NV has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Biocartis Group NV's Quick Ratio compare to TMO and DHR?
Biocartis Group NV's Quick Ratio of 1.60 can be compared against companies in the Medical Diagnostics & Research industry. The industry median Quick Ratio is 1.69. Biocartis Group NV's value of 1.60 is 5.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Diagnostics & Research company?
The median Quick Ratio among Medical Diagnostics & Research companies is 1.69, based on 214 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Biocartis Group NV's current Quick Ratio of 1.60 is 5.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Biocartis Group NV and its competitors. For the Medical Diagnostics & Research industry, the median Quick Ratio is 1.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biocartis Group NV's current Quick Ratio is 1.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biocartis Group NV stock overvalued right now?
Biocartis Group NV (LTS:0R72) has a current Quick Ratio of 1.60. The current Quick Ratio is 1.60 and 5.3% below the Medical Diagnostics & Research industry median of 1.69. Biocartis Group NV's overall GF Score™ is 14/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Biocartis Group NV (LTS:0R72), the current Quick Ratio is 1.60 as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biocartis Group NV Business Description

Address Generaal de Wittelaan 11 B, Mechelen, BEL, 2800
Biocartis Group NV is a commercial-stage molecular diagnostics company. It provides diagnostic solutions aimed at improving clinical practice for patients, clinicians, payers, and the industry. The firm has developed an Meet Idylla molecular diagnostic system for oncology and infectious disease segments.
14GF Score

Get the complete analysis for LTS:0R72

Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.30
Price